Alix K. Berglund, DVM, PhD
Especialidades y experiencia
- Immunology; Mesenchymal stem cell biology
Educación
- DVM: Washington State University
- PhD: North Carolina State University
Selección de premios, logros y publicaciones
- Koch DW, Schnabel LV, Ellis IM, Bates RE, Berglund AK. TGF-β2 enhances tendon healing-associated paracrine factors in equine bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2022;13:477.
- Berglund AK, Long JM, Robertson JB, Schnabel LV. TGF-β2 reduces the cell-mediated cytotoxicity of MHC-mismatched equine bone marrow-derived mesenchymal stem cells without altering immunomodulatory properties. Front Cell Dev Biol. 2021;9:628382.
- Berglund AK, Schnabel LV. Allogeneic MHC-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-MHC antibodies. Equine Vet J. 2017;49(4):539-544.
Capítulos y comentarios del manual
